David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APO.PRA
676
DELISTED
Apollo Global Management Series A
APO.PRA
| $54.4M | 0.03% |
895,000
+125,000
| +16% | +$8.1M |
|
677
HCA Healthcare
HCA
$93.7B
| $54.4M | 0.03% |
139,447
+89,512
| +179% | +$37.8M |
|
678
Williams Companies
WMB
$85.4B
| $54.4M | 0.03% |
731,245
-1,217,304
| -62% | -$89.6M |
|
679
Elevance Health
ELV
$86.5B
| $54.3M | 0.03% |
140,324
-265,668
| -65% | -$98.5M |
|
680
CALL
argenx
ARGX
$63.3B
| $54.1M | 0.03% |
58,300
-17,800
| -23% | -$14.7M |
|
681
Amkor Technology
AMKR
$11.9B
| $53.9M | 0.03% |
624,860
-863,905
| -58% | -$61.6M |
|
682
Butterfly Network
BFLY
$2.4B
| $53.8M | 0.03% |
6,392,827
+5,272,536
| +471% | +$27.3M |
|
683
PUT
BCE
BCE
$22.2B
| $53.7M | 0.03% |
2,494,000
-150,000
| -6% | -$3.6M |
|
684
CALL
Newmont
NEM
$138B
| $53.6M | 0.03% |
574,100
+302,900
| +112% | +$33M |
|
685
GSK
GSK
$103B
| $53.4M | 0.03% |
+1,019,449
| New | +$53.9M |
|
686
Snowflake
SNOW
$114B
| $53.4M | 0.03% |
209,813
+59,360
| +39% | +$10.9M |
|
687
PUT
Intuit
INTU
$101B
| $53.4M | 0.03% |
204,500
+128,400
| +169% | +$44.7M |
|
688
ConocoPhillips
COP
$161B
| $53.3M | 0.03% |
513,089
+79,272
| +18% | +$9.4M |
|
689
Novavax
NVAX
$1.41B
| $53.2M | 0.03% |
5,650,905
-2,058,953
| -27% | -$18.4M |
|
|
SF
690
Stifel
SF
$12.3B
| $53.2M | 0.03% |
762,408
+140,024
| +22% | +$10.4M |
|
691
Textron
TXT
$14.2B
| $53M | 0.03% |
578,134
-310,680
| -35% | -$28.2M |
|
692
Pebblebrook Hotel Trust
PEB
$2.08B
| $53M | 0.03% |
2,728,760
+1,872,055
| +219% | +$28.9M |
|
693
PUT
Chipotle Mexican Grill
CMG
$47.8B
| $52.5M | 0.03% |
1,545,000
+476,500
| +45% | +$15.6M |
|
|
RAL
694
Ralliant Corp
RAL
$6.92B
| $52.4M | 0.02% |
711,817
+634,147
| +816% | +$35.4M |
|
695
LyondellBasell Industries
LYB
$21.3B
| $52.1M | 0.02% |
990,499
+908,268
| +1,105% | +$62.7M |
|
696
CALL
TeraWulf
WULF
$7.88B
| $52.1M | 0.02% |
2,110,000
-1,410,000
| -40% | -$32.4M |
|
697
State Street SPDR S&P Biotech ETF
XBI
$11.4B
| $52M | 0.02% |
328,794
-1,038,998
| -76% | -$140M |
|
698
NovaGold Resources
NG
$4.05B
| $51.8M | 0.02% |
8,684,037
-850,580
| -9% | -$7.08M |
|
699
CALL
Rogers Communications
RCI
$19.5B
| $51.8M | 0.02% |
1,595,000
-250,000
| -14% | -$9.02M |
|
700
Kosmos Energy
KOS
$1.7B
| $51.8M | 0.02% |
24,538,308
+4,152,563
| +20% | +$11.6M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.